Cargando…

Association of Serum Apolipoprotein A5 Concentration with Nonalcoholic Fatty Liver Disease in Ningbo, China

Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease characterized by the excessive accumulation of hepatocyte fat and steatosis in the absence of alcohol or any other clear contributing factors to liver injury. NAFLD has been confirmed to be closely associated with obesity, insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiao, Xu, Ping, Tao, Xueping, Li, Wenli, Hong, Qiongyi, Cao, Qunfen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286930/ https://www.ncbi.nlm.nih.gov/pubmed/35854768 http://dx.doi.org/10.1155/2022/7015528

Ejemplares similares

Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)

Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease
por: Chen, Changxi, et al.
Publicado: (2022)

Knowledge and perceptions of air pollution in Ningbo, China
por: Qian, Xujun, et al.
Publicado: (2016)

Epidemiological Study on Metal Pollution of Ningbo in China
por: Li, Zhou, et al.
Publicado: (2018)

Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
por: Guomei, Cao, et al.
Publicado: (2022)

Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case‐control study
por: Liu, Sudong, et al.
Publicado: (2021)

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease
por: Kawaguchi, Kazunori, et al.
Publicado: (2021)

Ambient air pollution and years of life lost in Ningbo, China
por: He, Tianfeng, et al.
Publicado: (2016)

Effects of monthly evaluations on the rates of irrational antimicrobial prescription in the outpatient and emergency departments at Ningbo No. 6 Hospital, Ningbo, China
por: Yang, Qiong, et al.
Publicado: (2022)

Associations of Urinary Phytoestrogen Concentrations with Nonalcoholic Fatty Liver Disease among Adults
por: Xiong, Guang, et al.
Publicado: (2022)

HSPA8 Single-Nucleotide Polymorphism Is Associated with Serum HSC70 Concentration and Carotid Artery Atherosclerosis in Nonalcoholic Fatty Liver Disease
por: Zhao, Wenli, et al.
Publicado: (2022)

Body iron, serum ferritin, and nonalcoholic fatty liver disease
por: Shim, Jae-Jun
Publicado: (2012)

Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death
por: Paiva, Adriene A., et al.
Publicado: (2017)

Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease
por: Sun, Xulong, et al.
Publicado: (2020)

Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver Disease
por: Yamamoto, Reina, et al.
Publicado: (2023)

A super-spreader of COVID-19 in Ningbo city in China
por: Lin, Jie, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
por: Kwak, Min-Sun, et al.
Publicado: (2012)

Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population
por: Hu, Wen, et al.
Publicado: (2017)

Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease
por: Li, Jia, et al.
Publicado: (2019)

Serum metabolome alterations in patients with early nonalcoholic fatty liver disease
por: Wang, Xuemei, et al.
Publicado: (2022)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease
por: Britton, Laurence, et al.
Publicado: (2018)

The Incidence and Mortality of Cervical Cancer in Ningbo during 2006–2014, China
por: LI, Hui, et al.
Publicado: (2017)

Heritability of Serum Apolipoprotein Concentrations in Middle-Aged Japanese Twins
por: Cai, Yang Ping, et al.
Publicado: (2009)

An Equation to Estimate the Concentration of Serum Apolipoprotein B
por: Hwang, You-Cheol, et al.
Publicado: (2012)

Combining serum uric acid and fatty liver index to improve prediction quality of nonalcoholic fatty liver disease
por: Ding, Yajie, et al.
Publicado: (2023)

Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice
por: Han, Hao, et al.
Publicado: (2017)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

The Prevalence of Nonalcoholic Fatty Liver Disease and Relationship with Serum Uric Acid Level in Uyghur Population
por: Cai, Wen, et al.
Publicado: (2014)

The Relationship between Normal Serum Uric Acid and Nonalcoholic Fatty Liver Disease
por: Hwang, In-Cheol, et al.
Publicado: (2011)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
por: Jang, Byoung Kuk
Publicado: (2012)

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2016)

Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Kim, Min Chul, et al.
Publicado: (2020)

Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
por: Chen, Shenghui, et al.
Publicado: (2022)

Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease
por: Zeng, Yuping, et al.
Publicado: (2022)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
por: Chen, Hao-Kai, et al.
Publicado: (2023)

Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway
por: Lin, Min-Jie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_45uujlavm2n0r3haabuo5qbtsv